Time trends in statin utilisation and coronary mortality in Western European countries
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Time trends in statin utilisation and coronary mortality in Western European countries
Authors
Keywords
-
Journal
BMJ Open
Volume 6, Issue 3, Pages e010500
Publisher
BMJ
Online
2016-03-31
DOI
10.1136/bmjopen-2015-010500
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Increased risk of diabetes with statin treatment is associated with impaired insulin sensitivity and insulin secretion: a 6 year follow-up study of the METSIM cohort
- (2015) Henna Cederberg et al. DIABETOLOGIA
- Statins and New-Onset Diabetes Mellitus and Diabetic Complications: A Retrospective Cohort Study of US Healthy Adults
- (2015) Ishak Mansi et al. JOURNAL OF GENERAL INTERNAL MEDICINE
- Statin use in adults at high risk of cardiovascular disease mortality: cross-sectional analysis of baseline data from The Irish Longitudinal Study on Ageing (TILDA)
- (2015) Catriona Murphy et al. BMJ Open
- Rosuvastatin: winner in the statin wars, patients' health notwithstanding
- (2015) S. Wolfe BMJ-British Medical Journal
- Rosuvastatin: winner in the statin wars, patients' health notwithstanding
- (2015) S. Wolfe BMJ-British Medical Journal
- The impact of Regional co-payment and National reimbursement criteria on statins use in Italy: an interrupted time-series analysis
- (2014) Gianfranco Damiani et al. BMC HEALTH SERVICES RESEARCH
- Impact of statin adherence on cardiovascular disease and mortality outcomes: a systematic review
- (2014) Mary A. De Vera et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Cardiovascular disease in Europe 2014: epidemiological update
- (2014) Melanie Nichols et al. EUROPEAN HEART JOURNAL
- Family history of cardiovascular disease and influence on statin therapy persistence
- (2014) Anna Citarella et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Systematic review of factors affecting pharmaceutical expenditures
- (2014) Mohamed Awad Mousnad et al. HEALTH POLICY
- Multiple policies to enhance prescribing efficiency for established medicines in Europe with a particular focus on demand-side measures: findings and future implications
- (2014) Brian Godman et al. Frontiers in Pharmacology
- Starting statins for primary prevention of cardiovascular disease
- (2013) Hugh Tunstall-Pedoe HEART
- The efficiency of cardiovascular risk assessment: do the right patients get statin treatment?
- (2013) Tjeerd-Pieter van Staa et al. HEART
- Comparative benefits of statins in the primary and secondary prevention of major coronary events and all-cause mortality: a network meta-analysis of placebo-controlled and active-comparator trials
- (2013) Huseyin Naci et al. European Journal of Preventive Cardiology
- The potential influence of various initiatives to improve rational prescribing for proton pump inhibitors and statins in Belgium
- (2013) Jessica Fraeyman et al. Expert Review of Pharmacoeconomics & Outcomes Research
- General Practitioners’ coronary risk estimates, decisions to start lipid-lowering treatment, gender and length of clinical experience: their interactions in primary prevention
- (2013) Federico Vancheri et al. Primary Health Care Research and Development
- Proportion and Risk Indicators of Nonadherence to Statin Therapy: A Meta-analysis
- (2012) Mark Lemstra et al. CANADIAN JOURNAL OF CARDIOLOGY
- Statins for all?
- (2012) M. McCartney BMJ-British Medical Journal
- Ongoing measures to enhance the efficiency of prescribing of proton pump inhibitors and statins in The Netherlands: influence and future implications
- (2012) Menno van Woerkom et al. Journal of Comparative Effectiveness Research
- Soft regulations in pharmaceutical policy making
- (2012) Björn Wettermark et al. Applied Health Economics and Health Policy
- Proportion of the Decline in Cardiovascular Mortality Disease due to Prevention Versus Treatment: Public Health Versus Clinical Care
- (2011) Earl S. Ford et al. Annual Review of Public Health
- Achievement of treatment goals for primary prevention of cardiovascular disease in clinical practice across Europe: the EURIKA study
- (2011) J. R. Banegas et al. EUROPEAN HEART JOURNAL
- Utilization and costs of lipid modifying therapies following health technology assessment for the new reimbursement scheme in Sweden
- (2011) Billie Pettersson et al. HEALTH POLICY
- Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey
- (2011) Salim Yusuf et al. LANCET
- Bridging the efficacy–effectiveness gap: a regulator's perspective on addressing variability of drug response
- (2011) Hans-Georg Eichler et al. NATURE REVIEWS DRUG DISCOVERY
- Drug utilization according to reason for prescribing: a pharmacoepidemiologic method based on an indication hierarchy
- (2011) Helle Wallach Kildemoes et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Policies to Enhance Prescribing Efficiency in Europe: Findings and Future Implications
- (2011) Brian Godman et al. Frontiers in Pharmacology
- Statin prescription in men and women at cardiovascular risk: to whom and when?
- (2010) Jasper J Brugts et al. CURRENT OPINION IN CARDIOLOGY
- Association of Temporal Trends in Risk Factors and Treatment Uptake With Coronary Heart Disease Mortality, 1994-2005
- (2010) Harindra C. Wijeysundera JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Impact of Restricted Reimbursement on the Use of Statins in Finland
- (2010) Jaana E. Martikainen et al. MEDICAL CARE
- Efficacy and safety of statin treatment for cardiovascular disease: a network meta-analysis of 170 255 patients from 76 randomized trials
- (2010) E. J. Mills et al. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE
- Statin Adverse Effects
- (2009) Beatrice A Golomb et al. American Journal of Cardiovascular Drugs
- Explaining the Decrease in Coronary Heart Disease Mortality in Italy Between 1980 and 2000
- (2009) Luigi Palmieri et al. AMERICAN JOURNAL OF PUBLIC HEALTH
- Cardiovascular risk factor trends and options for reducing future coronary heart disease mortality in the United States of America
- (2009) Simon Capewell et al. BULLETIN OF THE WORLD HEALTH ORGANIZATION
- Modelling the decreasing coronary heart disease mortality in Sweden between 1986 and 2002
- (2009) Lena Björck et al. EUROPEAN HEART JOURNAL
- EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries
- (2009) Kornelia Kotseva et al. EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION
- Can individuals with a significant risk for cardiovascular disease be adequately identified by combination of several risk factors? Modelling study based on the Norwegian HUNT 2 population
- (2009) Halfdan Petursson et al. JOURNAL OF EVALUATION IN CLINICAL PRACTICE
- Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries
- (2009) Kornelia Kotseva et al. LANCET
- Driving forces behind increasing cardiovascular drug utilization: a dynamic pharmacoepidemiological model
- (2008) Helle Wallach Kildemoes et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Statin treatment in a cohort of 20 212 men and women in Norway according to cardiovascular risk factors and level of education
- (2008) Randi Selmer et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- What explains declining coronary mortality? Lessons and warnings
- (2008) S. Capewell et al. HEART
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now